Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

BDSI Might Again Be Ready For Prime Time
Seeking Alpha
Monday, January 9, 2012 - 9:55am
tags:
BioDelivery Sciences, BEMA Buprenorphine, Endo
S&P: Bristol-Myers announcement will not affect rating
Reuters
Monday, January 9, 2012 - 9:53am
tags:
Bristol-Myers Squibb, M&A, Inhibitex
UK cost agency wants more data on Bayer anti-clot drug
Reuters
Monday, January 9, 2012 - 9:52am
tags:
UK, Bayer, Xarelto
AstraZeneca reaffirms EPS guidance for 2011
Marketwatch
Monday, January 9, 2012 - 9:51am
tags:
AstraZeneca, guidance
Theravance Shares Slide on Lung Drug Deaths
TheStreet.com
Monday, January 9, 2012 - 9:51am
tags:
Relovair, GSK, Theravance
J&J to Oppose Texas in $1 Billion Trial Over Risperdal Marketing Practices
Bloomberg
Monday, January 9, 2012 - 9:23am
tags:
off-label, JNJ, Texas, Risperdal
Biotech drug makers aim to extend brand dominance
Reuters
Monday, January 9, 2012 - 9:18am
tags:
branding, biotech
Bristol-Myers to Acquire Inhibitex for $2.5 Billion
NY Times, NY
Monday, January 9, 2012 - 9:15am
tags:
Bristol-Myers Squibb, Inhibitex, M&A
Sector Snap: Specialty drugs in 2012
BusinessWeek
Sunday, January 8, 2012 - 12:58pm
tags:
Salix, Cubist Pharmaceuticals, Ironwood Pharmaceuticals, Emergent BioSolutions, Xifaxin, Cubicin, Alkermes, Questcor Pharmaceuticals
Boston lawsuit claims DES-breast cancer link
Yahoo/AP
Sunday, January 8, 2012 - 12:55pm
tags:
DES, breast cancer
China Biotech In Review: China Unveils Biotech Development Plan 2010-2020
Seeking Alpha
Sunday, January 8, 2012 - 12:53pm
tags:
AstraZeneca, China Kanghui, Ascletis
Ampio Is A Compelling Short Sale Idea
Seeking Alpha
Sunday, January 8, 2012 - 12:51pm
tags:
Ampio Pharmaceuticals
The Magic Formula for Biotech
Motley Fool
Sunday, January 8, 2012 - 12:50pm
tags:
Gilead, Amgen
Is Amgen's Stock Cheap by the Numbers?
Motley Fool
Sunday, January 8, 2012 - 12:48pm
tags:
Amgen
AVEO: More Open Questions Than Answers
Seeking Alpha
Sunday, January 8, 2012 - 12:47pm
tags:
Aveo Pharmaceutical, tivozanib, kidney cancer, renal cancer
The Law Office of James C. Kelly Announces Investigation of Inhibitex, Inc.
Yahoo/PR NewsWire
Sunday, January 8, 2012 - 12:44pm
tags:
Inhibitex, Bristol-Myers Squibb, M&A
Bristol to buy Inhibitex for hepatitis C treatment
Reuters
Sunday, January 8, 2012 - 12:42pm
tags:
INX-189, Inhibitex, hepatitis C, Bristol-Myers Squibb, M&A
Supernus Pharmaceuticals Raises $42 Million to Prepare for Launch of Product Candidates in Epilepsy and Develop Pipeline in ADHD
BioMedReports
Saturday, January 7, 2012 - 2:34pm
tags:
Supernus Pharmaceuticals, SPN-538, SPN-810, SPN-812, ADHD, epilepsy
KAI Pharmaceuticals Announces Initiation of Second Phase 2 Study of KAI-4169
BusinessWire
Saturday, January 7, 2012 - 2:32pm
tags:
KAI Pharmaceuticals, KAI-4169, dialysis
Syndax Pharma, Ventana Medical enter pact to develop companion diagnostic test for entinostat
Pharmabiz
Saturday, January 7, 2012 - 2:30pm
tags:
Syndax Pharma, Ventana Medical Systems

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.